A Phase I/IIa Safety and Efficacy Study of Nebulized Liposome-mediated Gene Therapy for Cystic Fibrosis Supports a Multidose Trial.

Alton EW, Boyd AC, Porteous DJ, Davies G, Davies JC, Griesenbach U, Higgins TE, Gill DR, Hyde SC, Innes JA

American Journal of Respiratory and Critical Care Medicine

AJRCCM, Volume 192, Pages 1389-1392

 Download the Manuscript

Print this page

Go Back to Publications     View on Pubmed (26623687)    View on Google Scholar